537 related articles for article (PubMed ID: 26865350)
21. Clinical Effects and Safety of 3% Diquafosol Ophthalmic Solution for Patients With Dry Eye After Cataract Surgery: A Randomized Controlled Trial.
Park DH; Chung JK; Seo DR; Lee SJ
Am J Ophthalmol; 2016 Mar; 163():122-131.e2. PubMed ID: 26685791
[TBL] [Abstract][Full Text] [Related]
22. The effect of an artificial tear combining hyaluronic acid and tamarind seeds polysaccharide in patients with moderate dry eye syndrome: a new treatment for dry eye.
Barabino S; Rolando M; Nardi M; Bonini S; Aragona P; Traverso CE
Eur J Ophthalmol; 2014; 24(2):173-8. PubMed ID: 24030535
[TBL] [Abstract][Full Text] [Related]
23. Carbomer and sodium hyaluronate eyedrops for moderate dry eye treatment.
Johnson ME; Murphy PJ; Boulton M
Optom Vis Sci; 2008 Aug; 85(8):750-7. PubMed ID: 18677239
[TBL] [Abstract][Full Text] [Related]
24. A Water-free 0.1% Cyclosporine A Solution for Treatment of Dry Eye Disease: Results of the Randomized Phase 2B/3 ESSENCE Study.
Sheppard JD; Wirta DL; McLaurin E; Boehmer BE; Ciolino JB; Meides AS; Schlüter T; Ousler GW; Usner D; Krösser S
Cornea; 2021 Oct; 40(10):1290-1297. PubMed ID: 34481407
[TBL] [Abstract][Full Text] [Related]
25. Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group.
Sall K; Stevenson OD; Mundorf TK; Reis BL
Ophthalmology; 2000 Apr; 107(4):631-9. PubMed ID: 10768324
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of sodium hyaluronate and carboxymethylcellulose in treating mild to moderate dry eye disease.
Lee JH; Ahn HS; Kim EK; Kim TI
Cornea; 2011 Feb; 30(2):175-9. PubMed ID: 21045674
[TBL] [Abstract][Full Text] [Related]
27. Effects of diquafosol sodium eye drops on tear film stability in short BUT type of dry eye.
Shimazaki-Den S; Iseda H; Dogru M; Shimazaki J
Cornea; 2013 Aug; 32(8):1120-5. PubMed ID: 23635860
[TBL] [Abstract][Full Text] [Related]
28. Autologous serum eye drops for dry eye after LASIK.
Noda-Tsuruya T; Asano-Kato N; Toda I; Tsubota K
J Refract Surg; 2006; 22(1):61-6. PubMed ID: 16447938
[TBL] [Abstract][Full Text] [Related]
29. Symptoms and signs of tear film dysfunction in glaucomatous patients.
Valente C; Iester M; Corsi E; Rolando M
J Ocul Pharmacol Ther; 2011 Jun; 27(3):281-5. PubMed ID: 21557633
[TBL] [Abstract][Full Text] [Related]
30. Corneal and conjunctival sensitivity in patients with dry eye: the effect of topical cyclosporine therapy.
Toker E; Asfuroğlu E
Cornea; 2010 Feb; 29(2):133-40. PubMed ID: 19966564
[TBL] [Abstract][Full Text] [Related]
31. Ocular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graft-versus-host disease.
Wang Y; Ogawa Y; Dogru M; Kawai M; Tatematsu Y; Uchino M; Okada N; Igarashi A; Kujira A; Fujishima H; Okamoto S; Shimazaki J; Tsubota K
Bone Marrow Transplant; 2008 Feb; 41(3):293-302. PubMed ID: 17982500
[TBL] [Abstract][Full Text] [Related]
32. An evaluation of the efficacy of fluorescein, rose bengal, lissamine green, and a new dye mixture for ocular surface staining.
Korb DR; Herman JP; Finnemore VM; Exford JM; Blackie CA
Eye Contact Lens; 2008 Jan; 34(1):61-4. PubMed ID: 18180687
[TBL] [Abstract][Full Text] [Related]
33. Clinical trials of therapeutic ocular surface medium for moderate to severe dry eye.
Watson SL; Daniels JT; Geerling G; Dart JK
Cornea; 2010 Nov; 29(11):1241-6. PubMed ID: 20697273
[TBL] [Abstract][Full Text] [Related]
34. Blood derived treatment from two allogeneic sources for severe dry eye associated to keratopathy: a multicentre randomised cross over clinical trial.
Campos E; Versura P; Buzzi M; Fontana L; Giannaccare G; Pellegrini M; Lanconelli N; Brancaleoni A; Moscardelli F; Sebastiani S; Vaselli C; Randi V
Br J Ophthalmol; 2020 Aug; 104(8):1142-1147. PubMed ID: 31744796
[TBL] [Abstract][Full Text] [Related]
35. A Clinical Phase II Study to Assess Efficacy, Safety, and Tolerability of Waterfree Cyclosporine Formulation for Treatment of Dry Eye Disease.
Wirta DL; Torkildsen GL; Moreira HR; Lonsdale JD; Ciolino JB; Jentsch G; Beckert M; Ousler GW; Steven P; Krösser S
Ophthalmology; 2019 Jun; 126(6):792-800. PubMed ID: 30703441
[TBL] [Abstract][Full Text] [Related]
36. Discomfort symptoms reduction and ocular surface parameters recovery with Artelac Rebalance treatment in mild-moderate dry eye.
Versura P; Profazio V; Giannaccare G; Fresina M; Campos EC
Eur J Ophthalmol; 2013; 23(4):488-95. PubMed ID: 23539457
[TBL] [Abstract][Full Text] [Related]
37. Rose bengal staining as an assessment of ocular surface damage and recovery in dry eye disease-a review.
Doughty MJ
Cont Lens Anterior Eye; 2013 Dec; 36(6):272-80. PubMed ID: 23928365
[TBL] [Abstract][Full Text] [Related]
38. Effect of Retinol Palmitate on Corneal and Conjunctival Mucin Gene Expression in a Rat Dry Eye Model After Injury.
Tabuchi N; Toshida H; Koike D; Odaka A; Suto C; Ohta T; Murakami A
J Ocul Pharmacol Ther; 2017; 33(1):24-33. PubMed ID: 28009531
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of dry eye syndrome in an adult population.
Hashemi H; Khabazkhoob M; Kheirkhah A; Emamian MH; Mehravaran S; Shariati M; Fotouhi A
Clin Exp Ophthalmol; 2014 Apr; 42(3):242-8. PubMed ID: 23927383
[TBL] [Abstract][Full Text] [Related]
40. A comparison of vitamin a and cyclosporine a 0.05% eye drops for treatment of dry eye syndrome.
Kim EC; Choi JS; Joo CK
Am J Ophthalmol; 2009 Feb; 147(2):206-213.e3. PubMed ID: 18848318
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
